Výsledky vyhledávání - "Päivi Pietilä‐Effati"

Akademický článek

30-Year Trends in the Incidence, Characteristics, and Outcome of Cardiac Sarcoidosis in a Nationwide Cohort

Autor: Pauli Pöyhönen, MD, MSc, Jukka Lehtonen, MD, Diana Velikanova, MD, Piia Simonen, MD, Valtteri Uusitalo, MD, Henriikka Mälkönen, MD, Hanna-Kaisa Nordenswan, MD, Tapani Vihinen, MD, Kari Kaikkonen, MD, Petri Haataja, MD, Tuomas Kerola, MD, Tuomas T. Rissanen, MD, Ville Vepsäläinen, MD, Aleksi Alatalo, MD, Päivi Pietilä-Effati, MD, Markku Kupari, MD

Publikováno v: JACC: Advances, Vol 3, Iss 8, Pp 101102- (2024)

Background: Cardiac sarcoidosis (CS) is a rare but potentially fatal inflammatory cardiomyopathy. Objectives: The authors studied temporal changes in the incidence, characteristics, and outcome of CS. Methods: A retrospective analysis was made of a 3

Externí odkaz: https://doaj.org/article/c7bb964c04b542a38e49cb21cbde217c

Zobrazit plný text záznamu

Akademický článek

Pulmonary manifestations and the effectiveness of enzyme replacement therapy in Fabry Disease with the p. Arg227Ter (p.R227*) mutation

Autor: Päivi Pietilä‐Effati, Johan Söderström, Jukka T. Saarinen, Eliisa Löyttyniemi, Ilkka Kantola

Publikováno v: Molecular Genetics & Genomic Medicine, Vol 10, Iss 5, Pp n/a-n/a (2022)

Abstract Background Fabry disease (FD) is caused by a defect in α‐galactosidase A gene (GLA) which leads to a progressive accumulation of neutral shingolipids, mainly globotriaosylceramide and its metabolites in several organs. Pulmonary manifesta

Externí odkaz: https://doaj.org/article/a76af33e41124870bcbce2226ec05a2e

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Manifestations and Outcome of Cardiac Sarcoidosis and Idiopathic Giant Cell Myocarditis by 25‐Year Nationwide Cohorts

Autor: Hanna‐Kaisa Nordenswan, Jukka Lehtonen, Kaj Ekström, Anne Räisänen‐Sokolowski, Mikko I. Mäyränpää, Tapani Vihinen, Heikki Miettinen, Kari Kaikkonen, Petri Haataja, Tuomas Kerola, Tuomas T. Rissanen, Jorma Kokkonen, Aleksi Alatalo, Päivi Pietilä‐Effati, Seppo Utriainen, Markku Kupari

Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 10, Iss 6 (2021)

Background Cardiac sarcoidosis (CS) and giant cell myocarditis (GCM) share many histopathologic and clinical features. Whether they are parts of a one‐disease continuum has been discussed. Methods and Results We compared medical record data of 351

Externí odkaz: https://doaj.org/article/e721c88217914129ba138dfcbf50dd48

Zobrazit plný text záznamu

Akademický článek

Natural course of Fabry disease with the p. Arg227Ter (p.R227*) mutation in Finland: Fast study

Autor: Päivi Pietilä‐Effati, Jukka T. Saarinen, Eliisa Löyttyniemi, Reijo Autio, Maria Saarenhovi, Maria K. Haanpää, Ilkka Kantola

Publikováno v: Molecular Genetics & Genomic Medicine, Vol 7, Iss 10, Pp n/a-n/a (2019)

Abstract Background Fabry disease is caused by a deficient or an absent alfa‐galactosidase A activity and is an X‐linked disorder that results in organ damage and a shortened life span, especially in males. The severity of the disease depends on

Externí odkaz: https://doaj.org/article/ebce6fa440654d8e89d6a8989064dcfe

Zobrazit plný text záznamu

Plný text ve formátu HTML

Cardiac Involvement in Fabry Disease

Autor: Mehdi Namdar, Albert Hagège, Eloisa Arbustini, Päivi Pietilä-Effati, Aleš Linhart, Roberto Barriales-Villa, Peter Nordbeck, Johanna Kuusisto, Iacopo Olivotto, Antonia Camporeale, Andreja Cokan Vujkovac, Perry M. Elliott, Maurizio Pieroni, James C. Moon

Publikováno v: Journal of the American College of Cardiology. 77:922-936

Fabry disease (FD) is a rare X-linked inherited lysosomal storage disorder caused by deficient α-galactosidase A activity that leads to an accumulation of globotriasylceramide (Gb3) in affected tissues, including the heart. Cardiovascular involvemen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::614addc2216fa0560a14f9eea42c7611
https://doi.org/10.1016/j.jacc.2020.12.024

Zobrazit plný text záznamu

Renal denervation in patients who do not respond to cardiac resynchronization therapy

Autor: Päivi Pietilä-Effati, Mathias Höglund, Aki Käräjämäki, Filip Höglund, Anne-Maria Nabb, Eija Matila, M. Juhani Koistinen

Publikováno v: Scandinavian cardiovascular journal : SCJ. 56(1)

Cardiac resynchronization therapy (CRT) reduces the morbidity and mortality in advanced heart failure (HF) in about two-thirds of the patients. Approximately one-third of the patients do not respond to CRT. The overactivity of sympathetic nervous sys

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6cffb437bcd953f32cd097b71bf0ad4
https://pubmed.ncbi.nlm.nih.gov/35587165

Zobrazit plný text záznamu

Plný text ve formátu HTML

Sudden death in cardiac sarcoidosis: an analysis of nationwide clinical and cause-of-death registries

Autor: Tuomas Kerola, Piia Simonen, Kaj Ekström, Kari S. Kaikkonen, Tuomas T. Rissanen, Hanna-Kaisa Nordenswan, Heikki Miettinen, Mikko I. Mäyränpää, Markku Kupari, Aleksi Alatalo, Jorma O. Kokkonen, Riina Kandolin, Tapani Vihinen, Päivi Pietilä-Effati, Seppo Utriainen, Anne Räisänen-Sokolowski, Petri Haataja, Jukka Lehtonen

Publikováno v: European Heart Journal. 40:3121-3128

Aims The present study was done to assess the role of sudden cardiac death (SCD) among the presenting manifestations of and fatalities from cardiac sarcoidosis (CS). Methods and results We analysed altogether 351 cases of CS presenting from year 1998

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3f06bbc26625feb88b1e2ca922ce147
https://doi.org/10.1093/eurheartj/ehz428

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání